Acorda Site #110 — Danbury, Connecticut

Acorda Site #110 is a clinical research site located in Danbury, Connecticut, United States 06810.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Acorda Site #110 has participated in 2 clinical trials.

Therapeutic areas: Post-ischemic Stroke, Post-Ischemic Stroke.

Sponsors: Acorda Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Danbury

Browse all research sites in Connecticut · View every site in Danbury

• CLINICAL RESEARCH CENTER OF CT, 27 Hospital Avenue
• Nuvance Health Danbury Hospital
• Danbury Hospital Praxair Cancer Center
• Praxair Cancer Center at Danbury Hospital
• Western Connecticut Hospital Systems
• Nuvance Health Danbury Hospital - Infectious Disease
• 8400371 - Danbury Hospital
• Danbury Hospital - Cardiology Department
• Danbury Hospital
• Danbury Hospital- Office of Clinical trials
• Nuvance Danbury Hospital
• The Danbury Hospital and the Western Connecticut Medical

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Acorda Site #110?

Acorda Site #110 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Acorda Site #110 conducted?

Acorda Site #110 has 2 clinical trials on record. Their work covers Post-ischemic Stroke, Post-Ischemic Stroke.

Is Acorda Site #110 accredited by Crixeo Clinical Trials?

Acorda Site #110 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Acorda Site #110?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.